These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

972 related items for PubMed ID: 29167896

  • 1. Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes.
    Hsieh YT, Tsai MJ, Tu ST, Hsieh MC.
    JAMA Ophthalmol; 2018 Jan 01; 136(1):68-74. PubMed ID: 29167896
    [Abstract] [Full Text] [Related]

  • 2. Association of diabetic retinopathy and diabetic macular oedema with renal function in southern Chinese patients with type 2 diabetes mellitus: a single-centre observational study.
    Zhuang X, Cao D, Yang D, Zeng Y, Yu H, Wang J, Kuang J, Xie J, Zhang S, Zhang L.
    BMJ Open; 2019 Sep 06; 9(9):e031194. PubMed ID: 31494622
    [Abstract] [Full Text] [Related]

  • 3. The Association of Estimated Glomerular Filtration Rate With Diabetic Retinopathy and Macular Edema.
    Man RE, Sasongko MB, Wang JJ, MacIsaac R, Wong TY, Sabanayagam C, Lamoureux EL.
    Invest Ophthalmol Vis Sci; 2015 Jul 06; 56(8):4810-6. PubMed ID: 26218909
    [Abstract] [Full Text] [Related]

  • 4. Time-sequential correlations between diabetic kidney disease and diabetic retinopathy in type 2 diabetes - an 8-year prospective cohort study.
    Hsieh YT, Hsieh MC.
    Acta Ophthalmol; 2021 Feb 06; 99(1):e1-e6. PubMed ID: 32567151
    [Abstract] [Full Text] [Related]

  • 5. Fasting plasma glucose variability is an independent risk factor for diabetic retinopathy and diabetic macular oedema in type 2 diabetes: An 8-year prospective cohort study.
    Hsieh YT, Hsieh MC.
    Clin Exp Ophthalmol; 2020 May 06; 48(4):470-476. PubMed ID: 32065699
    [Abstract] [Full Text] [Related]

  • 6. Correlation between markers of renal function and sight-threatening diabetic retinopathy in type 2 diabetes: a longitudinal study in an Indian clinic population.
    Rajalakshmi R, Shanthi Rani CS, Venkatesan U, Unnikrishnan R, Anjana RM, Jeba Rani S, UmaSankari G, Sivaprasad S, Raman R, Mohan V.
    BMJ Open Diabetes Res Care; 2020 May 06; 8(1):. PubMed ID: 32475840
    [Abstract] [Full Text] [Related]

  • 7. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.
    Jeng CJ, Hsieh YT, Yang CM, Yang CH, Lin CL, Wang IJ.
    Ophthalmol Retina; 2018 Jan 06; 2(1):38-45. PubMed ID: 31047300
    [Abstract] [Full Text] [Related]

  • 8. Impact of estimated glomerular filtration rate on diabetic macular edema.
    Temkar S, Karuppaiah N, Takkar B, Bhowmik D, Tripathi M, Ramakrishnan S, Sharma YR, Vohra R, Chawla R, Venkatesh P.
    Int Ophthalmol; 2018 Jun 06; 38(3):1043-1050. PubMed ID: 28523527
    [Abstract] [Full Text] [Related]

  • 9. Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.
    Meer E, Bavinger JC, Yu Y, VanderBeek BL.
    JAMA Ophthalmol; 2022 May 01; 140(5):529-532. PubMed ID: 35389455
    [Abstract] [Full Text] [Related]

  • 10. OCT Angiography Metrics Predict Progression of Diabetic Retinopathy and Development of Diabetic Macular Edema: A Prospective Study.
    Sun Z, Tang F, Wong R, Lok J, Szeto SKH, Chan JCK, Chan CKM, Tham CC, Ng DS, Cheung CY.
    Ophthalmology; 2019 Dec 01; 126(12):1675-1684. PubMed ID: 31358386
    [Abstract] [Full Text] [Related]

  • 11. Glomerular Filtration Rate and/or Ratio of Urine Albumin to Creatinine as Markers for Diabetic Retinopathy: A Ten-Year Follow-Up Study.
    Romero-Aroca P, Baget-Bernaldiz M, Navarro-Gil R, Moreno-Ribas A, Valls-Mateu A, Sagarra-Alamo R, Barrot-De La Puente JF, Mundet-Tuduri X.
    J Diabetes Res; 2018 Dec 01; 2018():5637130. PubMed ID: 29682579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Refractive Error and Retinopathy Outcomes in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.
    Hainsworth DP, Gao X, Bebu I, Das A, Olmos de Koo L, Barkmeier AJ, Tamborlane W, Lachin JM, Aiello LP, Diabetes Control and Complications Trial and Follow-up Epidemiology of Diabetes Interventions and Complications Research Group.
    Ophthalmology; 2021 Apr 01; 128(4):554-560. PubMed ID: 32941962
    [Abstract] [Full Text] [Related]

  • 15. The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy.
    Klein R, Lee KE, Danforth L, Tsai MY, Gangnon RE, Meuer SE, Wong TY, Cheung CY, Klein BEK.
    Ophthalmology; 2018 Nov 01; 125(11):1784-1792. PubMed ID: 29779685
    [Abstract] [Full Text] [Related]

  • 16. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes.
    Vail D, Callaway NF, Ludwig CA, Saroj N, Moshfeghi DM.
    Am J Ophthalmol; 2019 Nov 01; 207():378-384. PubMed ID: 31194953
    [Abstract] [Full Text] [Related]

  • 17. Association of Diabetic Macular Edema and Proliferative Diabetic Retinopathy With Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Xie J, Ikram MK, Cotch MF, Klein B, Varma R, Shaw JE, Klein R, Mitchell P, Lamoureux EL, Wong TY.
    JAMA Ophthalmol; 2017 Jun 01; 135(6):586-593. PubMed ID: 28472362
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
    Klein R, Myers CE, Lee KE, Paterson AD, Cruickshanks KJ, Tsai MY, Gangnon RE, Klein BE.
    JAMA Ophthalmol; 2015 Sep 01; 133(9):1054-61. PubMed ID: 26181138
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.